{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:31:43Z","timestamp":1793374303487,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["821RC1126"],"award-info":[{"award-number":["821RC1126"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012326"],"award-info":[{"award-number":["2022A1515012326"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070989"],"award-info":[{"award-number":["82070989"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jare.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T20:28:16Z","timestamp":1720643296000},"page":"121-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Exploitation of enhanced prime editing for blocking aberrant angiogenesis"],"prefix":"10.1016","volume":"72","author":[{"given":"Xionggao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2286-3934","authenticated-orcid":false,"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5824-4454","authenticated-orcid":false,"given":"Gaoen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2024.07.006_b0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jare.2024.07.006_b0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF03401566","article-title":"Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen","volume":"1","author":"Shima","year":"1995","journal-title":"Mol Med"},{"key":"10.1016\/j.jare.2024.07.006_b0015","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.1073\/pnas.94.14.7192","article-title":"Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site","volume":"94","author":"Muller","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2024.07.006_b0020","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.eye.6701476","article-title":"Epidemiology of diabetic retinopathy and macular oedema: a systematic review","volume":"18","author":"Williams","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jare.2024.07.006_b0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/ICU.0b013e3282fb7c45","article-title":"Update on treatments for diabetic macular edema","volume":"19","author":"Fraser-Bell","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jare.2024.07.006_b0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Group B-RC: Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2024.07.006_b0035","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1167\/iovs.10-5176","article-title":"The mouse retina as an angiogenesis model","volume":"51","author":"Stahl","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jare.2024.07.006_b0040","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","article-title":"investigators Is: Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial","volume":"382","author":"Chakravarthy","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2024.07.006_b0045","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.jare.2024.07.006_b0050","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.7150\/thno.26203","article-title":"Galphai1 and Galphai3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis","volume":"8","author":"Sun","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jare.2024.07.006_b0055","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.1074\/jbc.RA120.012590","article-title":"Interleukin-6-mediated epigenetic control of the VEGFR2 gene induces disorganized angiogenesis in human breast tumors","volume":"295","author":"Hegde","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2024.07.006_b0060","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.7150\/ijbs.82855","article-title":"SCF\/c-Kit-activated signaling and angiogenesis require Galphai1 and Galphai3","volume":"19","author":"Shan","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jare.2024.07.006_b0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/13543784.16.1.83","article-title":"VEGF\/VEGFR signalling as a target for inhibiting angiogenesis","volume":"16","author":"Kiselyov","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jare.2024.07.006_b0070","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/157488408784293705","article-title":"The molecular basis of class side effects due to treatment with inhibitors of the VEGF\/VEGFR pathway","volume":"3","author":"Roodhart","year":"2008","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.jare.2024.07.006_b0075","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/156800911795655985","article-title":"VEGF\/VEGFR pathway inhibitors as anti-angiogenic agents: Present and future","volume":"11","author":"Sharma","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.jare.2024.07.006_b0080","doi-asserted-by":"crossref","unstructured":"Uludag G, Hassan M, Matsumiya W, Pham BH, Chea S, Trong Tuong Than N, Doan HL, Akhavanrezayat A, Halim MS, Do DV, Nguyen QD: Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further? Expert Opin Biol Ther 2022:1-17.","DOI":"10.1080\/14712598.2022.2100694"},{"key":"10.1016\/j.jare.2024.07.006_b0085","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/07853890.2022.2064541","article-title":"VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy","volume":"54","author":"Arrigo","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.jare.2024.07.006_b0090","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/bjophthalmol-2013-304670","article-title":"Predictive factors for non-response to intravitreal ranibizumab treatment in age-related macular degeneration","volume":"98","author":"Suzuki","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jare.2024.07.006_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.03.045","article-title":"Therapeutic in vivo delivery of gene editing agents","author":"Raguram","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jare.2024.07.006_b0100","article-title":"The world's first CRISPR therapy is approved: who will receive it?","author":"Sheridan","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2024.07.006_b0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jare.2024.07.006_b0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41587-021-01039-7","article-title":"Engineered pegRNAs improve prime editing efficiency","volume":"40","author":"Nelson","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2024.07.006_b0115","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","article-title":"Designing and executing prime editing experiments in mammalian cells","volume":"17","author":"Doman","year":"2022","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jare.2024.07.006_b0120","doi-asserted-by":"crossref","unstructured":"Chen PJ, Hussmann JA, Yan J, Knipping F, Ravisankar P, Chen PF, Chen C, Nelson JW, Newby GA, Sahin M, Osborn MJ, Weissman JS, Adamson B, Liu DR: Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell 2021, 184:5635-52 e29.","DOI":"10.1016\/j.cell.2021.09.018"},{"key":"10.1016\/j.jare.2024.07.006_b0125","doi-asserted-by":"crossref","unstructured":"Doman JL, Pandey S, Neugebauer ME, An M, Davis JR, Randolph PB, McElroy A, Gao XD, Raguram A, Richter MF, Everette KA, Banskota S, Tian K, Tao YA, Tolar J, Osborn MJ, Liu DR: Phage-assisted evolution and protein engineering yield compact, efficient prime editors. Cell 2023, 186:3983-4002 e26.","DOI":"10.1016\/j.cell.2023.07.039"},{"key":"10.1016\/j.jare.2024.07.006_b0130","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ymthe.2022.01.005","article-title":"A flexible split prime editor using truncated reverse transcriptase improves dual-AAV delivery in mouse liver","volume":"30","author":"Zheng","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jare.2024.07.006_b0135","first-page":"118","article-title":"Precise genome engineering in Drosophila using prime editing","author":"Bosch","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2024.07.006_b0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41587-021-00901-y","article-title":"CRISPR prime editing with ribonucleoprotein complexes in zebrafish and primary human cells","volume":"40","author":"Petri","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2024.07.006_b0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41421-020-0165-z","article-title":"Efficient generation of mouse models with the prime editing system","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.jare.2024.07.006_b0150","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/s41467-021-22295-w","article-title":"Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2024.07.006_b0155","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41587-021-01026-y","article-title":"Deletion and replacement of long genomic sequences using prime editing","volume":"40","author":"Jiang","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2024.07.006_b0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41551-021-00788-9","article-title":"Application of prime editing to the correction of mutations and phenotypes in adult mice with liver and eye diseases","volume":"6","author":"Jang","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jare.2024.07.006_b0165","article-title":"A prime editor mouse to model a broad spectrum of somatic mutations in vivo","author":"Ely","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2024.07.006_b0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","article-title":"CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jare.2024.07.006_b0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2024.07.006_b0180","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/jvi.70.2.721-728.1996","article-title":"Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection","volume":"70","author":"Leavitt","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.jare.2024.07.006_b0185","doi-asserted-by":"crossref","first-page":"17684","DOI":"10.1073\/pnas.0606197103","article-title":"Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo","volume":"103","author":"Philippe","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2024.07.006_b0190","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ymthe.2006.01.008","article-title":"Transient gene expression by nonintegrating lentiviral vectors","volume":"13","author":"Nightingale","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.jare.2024.07.006_b0195","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1038\/srep06409","article-title":"Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases","volume":"4","author":"Mock","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2024.07.006_b0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41467-017-00140-3","article-title":"Genome editing abrogates angiogenesis in vivo","volume":"8","author":"Huang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2024.07.006_b0205","first-page":"9","article-title":"CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration","volume":"2018","author":"Koo","year":"1855","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2024.07.006_b0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/hum.2022.079","article-title":"Genome editing of Pik3cd impedes abnormal retinal angiogenesis","volume":"34","author":"Wu","year":"2023","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jare.2024.07.006_b0215","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1038\/ncomms14500","article-title":"In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni","volume":"8","author":"Kim","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2024.07.006_b0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","article-title":"Prime editing for precise and highly versatile genome manipulation","volume":"24","author":"Chen","year":"2023","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jare.2024.07.006_b0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-023-02078-y","article-title":"Engineered virus-like particles for transient delivery of prime editor ribonucleoprotein complexes in vivo","author":"An","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2024.07.006_b0230","article-title":"Efficient prime editing in mouse brain, liver and heart with dual AAVs","author":"Davis","year":"2023","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2024.07.006_b0235","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jare.2024.07.006_b0240","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/db19-0713","article-title":"PI3Kdelta as a novel therapeutic target in pathological angiogenesis","volume":"69","author":"Wu","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jare.2024.07.006_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.679906","article-title":"Tyrosine-protein phosphatase non-receptor type 9 (PTPN9) negatively regulates the paracrine vasoprotective activity of bone-marrow derived pro-angiogenic cells: Impact on vascular degeneration in oxygen-induced retinopathy","volume":"9","author":"Desjarlais","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jare.2024.07.006_b0250","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.1648","article-title":"Tracking genome engineering outcome at individual DNA breakpoints","volume":"8","author":"Certo","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.jare.2024.07.006_b0255","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41551-020-00622-8","article-title":"A web tool for the design of prime-editing guide RNAs","volume":"5","author":"Chow","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.jare.2024.07.006_b0260","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1073\/pnas.88.20.9026","article-title":"A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit","volume":"88","author":"Matthews","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2024.07.006_b0265","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nbt.3055","article-title":"In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9","volume":"33","author":"Swiech","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jare.2024.07.006_b0270","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1167\/iovs.16-20537","article-title":"Editing VEGFR2 blocks VEGF-induced activation of Akt and tube formation","volume":"58","author":"Huang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jare.2024.07.006_b0275","doi-asserted-by":"crossref","first-page":"e21152","DOI":"10.1096\/fj.201903105R","article-title":"Normal vitreous promotes angiogenesis via activation of Axl","volume":"35","author":"Wu","year":"2021","journal-title":"FASEB J"},{"key":"10.1016\/j.jare.2024.07.006_b0280","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.jare.2024.07.006_b0285","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1128\/MCB.01248-14","article-title":"RasGAP promotes autophagy and thereby suppresses platelet-derived growth factor receptor-mediated signaling events, cellular responses, and pathology","volume":"35","author":"Lei","year":"2015","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jare.2024.07.006_b0290","doi-asserted-by":"crossref","DOI":"10.1038\/s41374-022-00822-7","article-title":"Idelalisib inhibits experimental proliferative vitroretinopathy","author":"Dong","year":"2022","journal-title":"Lab Invest"},{"key":"10.1016\/j.jare.2024.07.006_b0295","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Stewart","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.jare.2024.07.006_b0300","doi-asserted-by":"crossref","unstructured":"Salmon P, Trono D: Production and titration of lentiviral vectors. Curr Protoc Hum Genet 2007, Chapter 12:Unit 12 0.","DOI":"10.1002\/0471142905.hg1210s54"},{"key":"10.1016\/j.jare.2024.07.006_b0305","doi-asserted-by":"crossref","unstructured":"Barde I, Salmon P, Trono D: Production and titration of lentiviral vectors. Curr Protoc Neurosci 2010, Chapter 4:Unit 4 21.","DOI":"10.1002\/0471142301.ns0421s53"},{"key":"10.1016\/j.jare.2024.07.006_b0310","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/01.RES.0000124979.46214.E3","article-title":"Heat shock protein 90alpha-dependent translocation of annexin II to the surface of endothelial cells modulates plasmin activity in the diabetic rat aorta","volume":"94","author":"Lei","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jare.2024.07.006_b0315","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","article-title":"HIV-1 integration in the human genome favors active genes and local hotspots","volume":"110","author":"Schroder","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jare.2024.07.006_b0320","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.gt.3302485","article-title":"Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier","volume":"12","author":"Gruter","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.jare.2024.07.006_b0325","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/gt.2014.57","article-title":"Retinal transduction profiles by high-capacity viral vectors","volume":"21","author":"Puppo","year":"2014","journal-title":"Gene Ther"},{"key":"10.1016\/j.jare.2024.07.006_b0330","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1073\/pnas.94.6.2386","article-title":"Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition","volume":"94","author":"Wang","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2024.07.006_b0335","first-page":"2406","article-title":"An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor","volume":"43","author":"Ikuno","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jare.2024.07.006_b0340","doi-asserted-by":"crossref","unstructured":"Narayan V, Barber-Rotenberg JS, Jung IY, Lacey SF, Rech AJ, Davis MM, Hwang WT, Lal P, Carpenter EL, Maude SL, Plesa G, Vapiwala N, Chew A, Moniak M, Sebro RA, Farwell MD, Marshall A, Gilmore J, Lledo L, Dengel K, Church SE, Hether TD, Xu J, Gohil M, Buckingham TH, Yee SS, Gonzalez VE, Kulikovskaya I, Chen F, Tian L, Tien K, Gladney W, Nobles CL, Raymond HE, Prostate Cancer Cellular Therapy Program I, Hexner EO, Siegel DL, Bushman FD, June CH, Fraietta JA, Haas NB: PSMA-targeting TGFbeta-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial. Nat Med 2022, 28:724-34.","DOI":"10.1038\/s41591-022-01726-1"},{"key":"10.1016\/j.jare.2024.07.006_b0345","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1089\/10430349950018111","article-title":"Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2","volume":"10","author":"Machein","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jare.2024.07.006_b0350","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1054>3.0.CO;2-Q","article-title":"Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants","volume":"91","author":"Stratmann","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jare.2024.07.006_b0355","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1524-475X.2002.10405.x","article-title":"Retroviral delivery of dominant-negative vascular endothelial growth factor receptor type 2 to murine wounds inhibits wound angiogenesis","volume":"10","author":"Tsou","year":"2002","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jare.2024.07.006_b0360","first-page":"2","article-title":"Ocular immune privilege","author":"Zhou","year":"2010","journal-title":"F1000 Biol Rep"},{"key":"10.1016\/j.jare.2024.07.006_b0365","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/eye.2008.382","article-title":"Ocular immune privilege","volume":"23","author":"Taylor","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.jare.2024.07.006_b0370","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1167\/iovs.19-28632","article-title":"The eye sees eye to eye with the immune system: The 2019 proctor lecture","volume":"60","author":"Niederkorn","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jare.2024.07.006_b0375","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1200\/JCO.2007.11.5113","article-title":"Hypertension, proteinuria, and antagonism of vascular endothelial growth factor signaling: clinical toxicity, therapeutic target, or novel biomarker?","volume":"25","author":"van Heeckeren","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2024.07.006_b0380","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/phar.1147","article-title":"Antiangiogenic therapy for cancer: an update","volume":"32","author":"Al-Husein","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jare.2024.07.006_b0385","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jare.2024.07.006_b0390","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2024.07.006_b0395","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Group VISiONCT: Pegaptanib for neovascular age-related macular degeneration","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jare.2024.07.006_b0400","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00417-021-05547-9","article-title":"Comparison of agents using higher dose anti-VEGF therapy for treatment-resistant neovascular age-related macular degeneration","volume":"260","author":"Broadhead","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jare.2024.07.006_b0405","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ophtha.2021.07.009","article-title":"Intravitreal pharmacotherapies for diabetic macular edema: A report by the American Academy of Ophthalmology","volume":"129","author":"Ehlers","year":"2022","journal-title":"Ophthalmology"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224002728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123224002728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:54:01Z","timestamp":1762599241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123224002728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":81,"alternative-id":["S2090123224002728"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2024.07.006","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploitation of enhanced prime editing for blocking aberrant angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}